Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.

Danijel SikicBastian KeckSven WachHelge TaubertBernd WullichPeter J GoebellAndreas KahlmeyerPeter OlbertPhilipp IsfortWilhelm NimphiusArndt HartmannJohannes Giedlnull null

Published in: PloS one (2017)

Immunohistochemical subgrouping of upper tract urothelial carcinomas by analyzing CK5 and CK20 expression can be performed in a routine setting and can identify tumors with a significantly worse cancer-specific survival prognosis.

Keyphrases

poor prognosis
urinary tract
protein kinase
high grade
long non coding rna
papillary thyroid
clinical practice
free survival